Showing results (2421-2430 of 2,473) with videos related to
Sort By:
Pageof 248
Cancer Treatment Reviews|June 21, 2024
The role of locoregional surgery in de novo stage IV breast cancer: A meta-analysis of randomized controlled trialsWenqi Zhou, Yeli Yue, Jing Xiong, et al.Cancer Treatment Reviews|June 22, 2024
Circulating tumor DNA-based assessment of molecular residual disease in non-metastatic melanomaEdoardo De Simoni, Francesco Spagnolo, Sara Gandini, et al.Cancer Treatment Reviews|June 21, 2024
The incidence of immune-related adverse events (irAEs) and their association with clinical outcomes in advanced renal cell carcinoma and urothelial carcinoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysisYaowen Zhang, Junru Chen, Haoyang Liu, et al.Cancer Treatment Reviews|November 5, 2023
Resistance mechanism to fibroblast growth factor receptor (FGFR) inhibitors in cholangiocarcinomaAngela Lamarca, Lorena Ostios, Mairéad G McNamara, et al.Cancer Treatment Reviews|November 17, 2023
Recent advances in genomics and therapeutics in mantle cell lymphomaTingxun Lu, Jie Zhang, Jenna M McCracken, et al.Cancer Treatment Reviews|November 20, 2023
Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencingAlbrecht Stenzinger, Arndt Vogel, Ulrich Lehmann, et al.Cancer Treatment Reviews|October 21, 2023
ESR1 mutations in HR+/HER2-metastatic breast cancer: Enhancing the accuracy of ctDNA testingKonstantinos Venetis, Francesco Pepe, Carlo Pescia, et al.Cancer Treatment Reviews|April 11, 2024
Clinical recommendations for treatment of localized angiosarcoma: A consensus paper by the Italian Sarcoma GroupElena Palassini, Giacomo Giulio Baldi, Sara Sulfaro, et al.Cancer Treatment Reviews|August 12, 2023
Liquid biopsy after resection of pancreatic adenocarcinoma and its relation to oncological outcomes. Systematic review and meta-analysisLaura Vidal, Elizabeth Pando, Laia Blanco, et al.Cancer Treatment Reviews|January 11, 2024
Current and emerging treatment approaches for hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancerKomal Jhaveri, Frederik MarméPageof 248